ARIDOL (mannitol) by Otsuka is 12. Approved for asthma. First approved in 2010.
Drug data last refreshed 20h ago
12.1 Mechanism of Action The precise mechanisms through which inhaled mannitol causes bronchoconstriction are not known. 12.2 Pharmacodynamics The response to inhaled mannitol is reported as the delivered dose of mannitol causing a 15% reduction in FEV 1 and is expressed as PD 15 . 12.3…
Worked on ARIDOL at Otsuka? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Inhaled Mannitol on Mucociliary Clearance in Moderate to Severe Cystic Fibrosis
PT027 Compared to PT007 in Patients With Asthma With Mannitol-induced Acute Airway Obstruction
Mannitol-Induced Cough Challenge in Healthy Controls and Subjects With Mild Allergic Asthma
A Study Comparing Picoprep With Mannitol and Bisacodyl for Colon Cleansing in Preparation for Colonoscopy
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo